Court Approves 23andMe Sale to TTAM Research Institute

23andMe's Ex-CEO Anne Wojcicki Made Privacy Pledge With Successful Bid of $305M Marianne Kolbasuk McGee (HealthInfoSec) • July 2, 2025

A federal bankruptcy court this week gave the green light for TTAM Research Institute - a new company launched by 23andMe's co-founder and former CEO Anne Wojcicki - to buy 23andMe. As part of TTAM's $305 million bid, it promised to uphold the consumer genetics testing firm's current privacy policies and implement additional data safeguards.

See Also: Flip the Security Model for Regulated Data Protection

Under the deal, TTAM will acquire all the assets of the health and ancestry testing company, including 23andMe's Personal Genome Service and Research Services business lines, and its Lemonaid telehealth business. The sale ...